The company reportedly said that two of its facilities have undergone inspection by US health regulator USFDA, which has issued observations for one unit.
Aurobindo Pharma was down by 3% at Rs. 779. The company reportedly said that two of its facilities have undergone inspection by USFDA, which has issued observations for one unit.
The company is appropriately responding and this has no perceived impact on operations and exports from the said facility, company added.
The scrip opened at Rs. 804 and has touched a high and low of Rs. 807.85 and Rs. 775 respectively. So far 614141 (NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 46832.35 crore.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 891.5 on 30-Dec-2015 and a 52 week low of Rs. 490.5 on 26-Feb-2015. Last one week high and low of the scrip stood at Rs. 837.5 and Rs. 792.4 respectively.
The promoters holding in the company stood at 53.9%, while Institutions and Non-Institutions held 35.24% and 10.86% respectively.
The stock is currently trading above its 50 DMA.
No comments:
Post a Comment